Literature DB >> 32000109

Human STAT1 gain-of-function iPSC line from a patient suffering from chronic mucocutaneous candidiasis.

Kathrin Haake1, Tim Wüstefeld2, Sylvia Merkert3, Doreen Lüttge2, Gudrun Göhring4, Bernd Auber4, Ulrich Baumann5, Nico Lachmann6.   

Abstract

Chronic mucocutaneous candidiasis (CMC) is a disease that is characterized by susceptibility to chronic or recurrent infections with Candida spp. due to mutations affecting mainly the IL-17 signaling of T-Cells. The most common etiologies of CMC are gain-of-function (GOF) mutations in the STAT1 gene. In this paper we report the generation of a hiPSC line from a patient suffering from CMC due to a heterozygous GOF STAT1 p.R274Q mutation which can be used for disease modeling purposes.
Copyright © 2020 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32000109     DOI: 10.1016/j.scr.2020.101713

Source DB:  PubMed          Journal:  Stem Cell Res        ISSN: 1873-5061            Impact factor:   2.020


  4 in total

1.  Generation of Human iPSC from Small Volume Peripheral Blood Samples.

Authors:  Doreen Kloos; Nico Lachmann
Journal:  Methods Mol Biol       Date:  2022

Review 2.  Human STAT1 Gain-of-Function Heterozygous Mutations: Chronic Mucocutaneous Candidiasis and Type I Interferonopathy.

Authors:  Satoshi Okada; Takaki Asano; Kunihiko Moriya; Stephanie Boisson-Dupuis; Masao Kobayashi; Jean-Laurent Casanova; Anne Puel
Journal:  J Clin Immunol       Date:  2020-08-27       Impact factor: 8.317

3.  Chronic Candida infection, bronchiectasis, immunoglobulin abnormalities, and stunting: a case report of a natural mutation of STAT1 (c.986C>G) in an adolescent male.

Authors:  Yali Yu; Fei Xu; Hui Shen; Jiang Wu
Journal:  BMC Infect Dis       Date:  2021-01-07       Impact factor: 3.090

4.  Gain-of-function STAT1 mutation and visceral leishmaniasis.

Authors:  Paula Teixeira Lyra; Ana Carla Augusto Moura Falcão; Rafael Amora Cruz; Antonio Victor Campos Coelho; Edvaldo da Silva Souza; Luiz Claudio Arraes de Alencar; João Bosco Oliveira
Journal:  Einstein (Sao Paulo)       Date:  2022-09-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.